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The Transient Receptor Potential Melastatin 4 protein (TRPM4) is a member of the TRP 
family of ion channels that is expressed in both electrically excitable and non-excitable 
cells. Functional studies revealed that TRPM4 significantly impacts Ca2+ signals in both 
immune and pancreatic β-cells, which is important for cellular processes such as hormone 
secretion. However, its role in glucagon secreting α-cells has not been reported. Type 2 
Diabetes Mellitus is often associated with increased glucagon levels; yet, the exact 
mechanism controlling its secretion is not known. In pancreatic α-cells, an increase in 
intracellular Ca2+ concentration causes glucagon secretion. We hypothesize that TRPM4 
is important for glucagon secretion in α-cells by controlling intracellular Ca2+ signals. In 
this study, we investigated TRPM4 expression in the α-cell lines INR1G9 (hamster) and 
αTC1-6 (mouse) and characterized the channel using the patch-clamp technique. By RT-
PCR we identified TRPM4-transcripts in both cell lines examined. Furthermore, patch-
clamp recordings with increasing intracellular Ca2+ concentrations resulted in a dose-
dependent activation of TRPM4-like currents. The greatest depolarizing currents were 
obtained with 3µM Ca2+ concentration. The current-voltage relationship (I/V) resembled 
those previously described for TRPM4. In addition, we demonstrated the voltage 
dependency of the channel, where negative potentials inhibited and positive potentials 
increased channel activity. Finally, replacement of Na+ ions in the extracellular solution 
with N-methyl-D-glucamine significantly reduced the inward currents and caused a 
hyperpolarizing shift in the I/V, which affirms that the channel is Na+ permeable. These 
data demonstrate that TRPM4 is present and functional in pancreatic α-cells and suggest 
a potential role for the channel in glucagon secretion and glucose homeostasis. The role 
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of TRPM4 in glucagon secretion was assessed using a stable TRPM4 knockdown αTC1-
6 cell line. Calcium-imaging and glucagon secretion experiments revealed a relationship 
between the decreased intracellular Ca2+ concentration and glucagon secretion in TRPM4 
knockdown cells compared to controls. These results indicate that depolarization by 
TRPM4 plays an important role in glucagon secretion and perhaps glucose homeostasis. 
Elucidation of the glucagon secretion pathway could lead to a treatment for 






1.1 THESIS ORGANIZATION 
This thesis is written in the journal style format. It contains an acknowledgements 
section, a general introduction, one research paper, a general conclusion, and a list of 
references cited in the general introduction and conclusion. The general introduction 
includes a hypothesis, objectives, background information, and a literature review. 
Chapter 2 is a research paper entitled “Regulation of Calcium-entry in Pancreatic α-cells 
by Transient Receptor Potential Melastatin 4 Plays Vital Role in Glucagon Release” that 
has been submitted to Molecular and Cellular Endocrinology and is currently under 
review. The general discussion will address the overall findings of this work. This thesis 
contains experimental results obtained by the author during her graduate study under the 
supervision of her co-major professors, Drs. Henrique Cheng and Ji-Ming Feng. 
 
1.2 RESEARCH OBJECTIVES 
 Based on previous work, we know that TRPM4 is able to control the Ca2+ signals 
of pancreatic β-cells to regulate insulin release (Cheng et al., 2007; Marigo et al., 2009). 
Depolarization by TRPM4 controls the opening of voltage-dependent Ca2+ channels 
allowing for Ca2+-dependent exocytosis of insulin granules. In an effort to elucidate the 
mechanism of glucagon secretion, we consider the role of TRPM4 in controlling Ca2+ 
signals that result in the exocytosis of glucagon granules. We hypothesize that TRPM4 is 
important for glucagon secretion in α-cells by controlling intracellular Ca2+ signals. 
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Because TRPM4 has not previously been studied in pancreatic α-cells, we will 1) identify 
and characterize TRPM4 in pancreatic α-cells then, 2) evaluate the role of TRPM4 in 
glucagon secretion. 
 
1.3 BACKGROUND AND LITERATURE REVIEW 
The family of Transient Receptor Potential (TRP) ion channels was originally 
identified in the Drosophila visual system. From there, eight subfamilies were identified 
in organisms ranging from C. elegans to humans (Fig. 1.1). Most TRP channels share a 
similar basic structure containing 6 transmembrane domains, a hydrophobic pore region 
between domains 5 and 6, and the C and N terminal regions on the intracellular side of 
the membrane. The TRP channels form homomeric or heteromeric tetramers in the cell 
membrane. However, the ionic permeability and activation vary greatly among the 
members of each subfamily. Functional studies of the TRP channels have implied 
physiological as well as pathophysiological roles for many of these channels (for review, 
see Nelson et al., 2010). 
 The first subfamily identified is the TRPC (canonical). This subfamily is most 
closely related to the Drosophila TRP channel subfamily and is the most well studied. 
Acting mainly as Ca2+ regulators, the TRPC channels play a major role in the 
maintenance of cellular Ca2+ homeostasis. This is important for processes such as 
keratinocyte differentiation (Beck et al., 2008), immune response (Sel et al., 2008; White 
et al., 2006), and muscle contraction (Tsvilovskyy et al., 2009). The vanilloid subfamily 
(TRPV) is named after their activation by vanilloid and vanilloid-like compounds such as 
capsaicin. These channels function as cellular heat and pH sensors (Geppetti et al., 2006) 
 3 
as well as nociceptors (Caterina et al., 1997; Tominaga et al., 1998). The TRPN (no 
mechanopotential C or NOMPC) has no mammalian members. The ankyrin (TRPA) 
subfamily has only one mammalian member, which acts as a nociceptor as well as a 
mechanosensor aiding in the cochlear amplification of sound (Corey et al., 2004; Nagata 
et al., 2005). The TRPML (mucolipin) channels serve a lysosomal role in mammals, and 
mutations of the TRPML genes are normally associated with lysosomal storage diseases 
(Bargal et al., 2000; Bassi et al., 2000; Sun et al., 2000) and hearing loss (van Aken et al., 
2008). The TRP channels associated with polycystic kidney disease make up the TRPP 
(polycystin) subfamily. These channels are located in the plasma membrane and sense 
mechanical stimulation such as fluid movement (Harris et al., 2006).   
             
Figure 1.1: Transient Receptor Potential channel subfamilies. Modified from 
Christensen and Corey, 2007 and Hoenderop et al., 2005. 
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 The melastatin (TRPM) subfamily is composed of 8 members that can be divided 
into subgroups based on their structural similarity. The founding member, TRPM1, is 
named after a pigment found in melanoma cells. Calcium signaling through TRPM1 is 
thought to be involved in melanocyte differentiation, migration, and survival (Bellone et 
al., 2008). Structurally similar to TRPM1, TRPM3 responds to hypotonic conditions 
resulting in cell swelling and is important for Ca2+ homeostasis in the kidneys (Grimm et 
al., 2003). Both TRPM6 and TRPM7 are activated by low intracellular Mg2+. TRPM7 is 
involved in cellular Mg2+ homeostasis (Schmitz et al., 2003); and TRPM6 plays a role in 
Mg2+ homeostasis specifically in the epithelium of the kidneys and intestines (Rondon et 
al., 2008; Voets et al., 2004). Deletion of the TRPM7 gene also disturbs normal growth 
and development in mice and zebrafish (Elizondo et al., 2005; Jin et al., 2008). The 
activation of TRPM2 by intracellular adenosine-diphosphoribose (ADP-ribose) and 
reactive oxygen species (Perraud et al., 2001; Sano et al., 2001) suggests a role for this 
channel in oxidative stress and cell death (Hara et al., 2002). TRPM8 functions as a 
cellular cold-sensor activated by cold temperatures and menthol (McKemy et al., 2002; 
Peier et al., 2002). Activation of a truncated form of TRPM8 in the lungs leads to 
cytokine production (Sabnis et al., 2008). 
Of all the TRPM channels, only TRPM4/5 are impermeable to Ca2+. TRPM4/5 
share a sequence homology of 45% (Hofmann et al., 2003). They are only permeable to 
monovalent cations (e.g. Na+ and K+); however, they are activated by intracellular Ca2+ 
(Launay et al., 2002; Prawitt et al., 2003). They belong to a group referred to as Ca2+-
activated nonselective (CAN) cation channels. Because they are not permeable to Ca2+, 
TRPM4/5 play an indirect role in regulating intracellular Ca2+. Intracellular Ca2+ activates 
TRPM4/5 resulting in Na+ influx followed by membrane depolarization (Launay et al., 
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2002; Prawitt et al., 2003). This depolarization controls Ca2+ entry through store-operated 
Ca2+ channels (SOCs) in non-excitable cells and voltage-dependent Ca2+ channels 
(VDCCs) in excitable cells (Launay et al., 2004; Marigo et al., 2009). The depolarization 
effect by TRPM4/5 depends on the cell type. In excitable cells, such as cardiac and 
skeletal muscle cells, endocrine cells, and neural cells, depolarization causes an increase 
in Ca2+ entry through VDCCs. Calcium influx through VDCCs depends on 2 factors: 
driving force of Ca2+ through the channel and activation state of the channel. During 
depolarization the membrane potential approaches 0mV. At 0mV, conditions are optimal 
for Ca2+ entry through VDCCs, because there is driving force and channel activation. 
However, in non-excitable cells such as endothelial cells or immune cells, depolarization 
inhibits Ca2+ entry through their major Ca2+ channels, SOCs due to a decrease in driving 
force for Ca2+.  
Because Ca2+ is an important second messenger in a number of physiological 
processes and intracellular Ca2+ activates TRPM4/5, it is likely that these channels are 
critical for cell physiology. TRPM5 is not as widely expressed as TRPM4; it was first 
identified in the taste receptors where it is involved in taste perception for sweet, bitter, 
and umami flavors (Perez et al., 2002; Zhang et al., 2003). TRPM5 has also been found 
in the olfactory system where it is involved in the processing of olfactory sensory 
information (Lin et al., 2007). Following its identification in the pancreatic β-cells 
(Prawitt et al., 2003), Colsoul and colleagues assessed the role of TRPM5 in these cells 
(Colsoul et al., 2010). They found that inhibition of TRPM5 decreased Ca2+ signals and 
insulin secretion; however, since TRPM4 is also present in β-cells, it is not known the 
contribution each one has on insulin secretion.  
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Widely expressed throughout the body, TRPM4 is implicated in a variety of 
functions throughout the mammalian system in both excitable and non-excitable cells. 
The role of TRPM4 was first described in immune cells where channel inhibition 
increases Ca2+ entry resulting in an increase in cytokine production by T-cells (Launay et 
al., 2004). The deletion of TRPM4 in mast cells had a similar effect on Ca2+ signaling 
leading to cellular degranulation and increased immune response (Vennekens et al., 
2007). Other studies found TRPM4 to be responsible for controlling mast cell and 
dendritic cell migration (Barbet et al., 2008; Shimizu et al., 2009). TRPM4 plays an 
indirect role in non-excitable vascular smooth muscle cells where inhibition reduces 
myogenic constriction affecting blood flow to the brain (Earley et al., 2004). The studies 
of TRPM4’s role in excitable cells are less numerous. The role of TRPM4 in excitable 
sino-atrial node cells was assessed and is suspected to aid in the pacemaker function 
(Demion et al., 2007). Another type of excitable cells, the pancreatic β-cells, was also 
studied. In these cells, inhibition of TRPM4 decreases Ca2+ signals and insulin secretion 
(Cheng et al., 2007; Marigo et al., 2009). In this system TRPM4 provides the 
depolarization necessary to open VDCCs thus, it controls Ca2+-activated exocytosis of 
insulin granules.  
 The pancreatic α-cells produce the hormone, glucagon, to counteract the effects of 
insulin. Glucagon is secreted from the α-cells in response to hypoglycemia. It acts on the 
liver to induce glycogenolysis and gluconeogenesis. Glucagon receptors are located in the 
liver, heart, kidney, spleen, stomach, thymus, adipose tissue, and pancreas (Dunphy et al., 
1998; Hansen et al., 1995). The precise mechanism for stimulation of glucagon secretion 
is not known. The pancreatic islets are innervated with sympathetic and parasympathetic 
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neurons, and the presence of receptors for their respective neurotransmitters in α-cells is 
suspected (for review, see Ahren, 2000).  
There is a disagreement among studies as to whether or not α-cells sense 
hypoglycemic conditions directly or through paracrine or autonomic signals. The school 
of thought that believes α-cells directly sense blood glucose levels are left with the task of 
explaining how high glucose can stimulate insulin secretion in β-cells while inhibiting 
glucagon secretion from α-cells. Many studies suggest that a voltage-dependent Na+ 
channel that inactivates at voltages beyond -50mV is present in α-cells but not in β-cells. 
It allows the α-cell to secrete glucagon up to a point when glucose metabolism 
depolarizes the membrane beyond -50mV (Barg et al., 2000; Gopel et al., 2000; 
MacDonald et al., 2007; Vieira et al., 2007). The group who believes that α-cells only 
respond to paracrine and autonomic signals of hypoglycemia argue that intravenous 
administration of glucose to diabetic humans (Greenbaum et al., 2002) and dogs (Braaten 
et al., 1974) with failing β-cells increases glucagon secretion. However, Salehi and 
colleagues noted a paradoxical response where glucose stimulates glucagon secretion in 
an alpha-cell line and isolated islets (Salehi et al., 2006), and others found that there is 
decreased glucagon response in hyperinsulinemic hypoglycemic infants (Hussain et al., 
2005). These studies suggest that autonomic input or paracrine input from functional β-
cells is required for proper glucagon response to hyperglycemic conditions. 
 Exocytosis, like many other physiological processes, is highly dependent on 
intracellular Ca2+ levels. The exocytosis of insulin granules is regulated by Ca2+ entry 
through VDCCs under the control of TRPM4 (Cheng et al., 2007; Marigo et al., 2009). 
TRPM5 has also been suggested to contribute to the Ca2+ oscillations associated with 
insulin secretion, however the mechanism of TRPM5 action is not clear (Colsoul et al., 
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2010). The exocytosis of glucagon granules from pancreatic α-cells is also dependent on 
intracellular Ca2+ concentration ([Ca2+]i). Still, the mechanism for glucagon secretion is 
unknown. Exocytosis of glucagon granules depends on electrical activity (Barg et al., 
2000) and Ca2+ entry through VDCCs (Gromada et al., 1997). But, the source initiating 
the Ca2+ current is under question. In the α-cell there are several types of VDCCs, the 
most abundant is the L-type. The identification of the non-L-type VDCCs is still unclear 
but may be T-, N-, R-, or P-types depending on the species and the particular study 
(Gopel et al., 2000; Gromada et al., 1997; Vignali et al., 2006). Although most Ca2+ 
enters through L-type VDCCs, one study suggests that this type of VDCC is not 
responsible for Ca2+ entry that results in exocytosis, but that N-type VDCCs serve the 
function of inducing glucagon release except in conditions that increase cAMP (Gromada 
et al., 1997). Regardless of the type of VDCC, this process relies on depolarization (Barg 
et al., 2000). The positively charged amino acid, L-arginine, can directly depolarize the 
membrane increasing the electrical activity and glucagon secretion (Barg et al., 2000; 
Gromada et al., 1997). Neurotransmitters such as adrenaline also stimulate glucagon 
secretion by mobilizing Ca2+ from the ER stores via the Gs-protein coupled receptor 
pathway that increases cAMP (Gromada et al., 1997). Interestingly, the pancreases of 
Type 2 diabetic patients have been found to contain higher levels of adrenaline (Ostenson 
et al., 1993), and its α-cells display an enhanced response to adrenaline (Ahren et al., 
1995). This may explain the source of stimulation for the hyperglucagonemia seen in 
diabetics (Dinneen et al., 1995; Unger, 1978). 
 Considering the regulatory role that TRPM4 plays on Ca2+ entry in β-cells, we 
suspect that TRPM4 could also control the Ca2+ entry in α-cells (Fig. 1.2). Both cell types 
are excitable, contain VDCCs opened by depolarization as their major Ca2+ channel, and 
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rely on Ca2+ entry to stimulate exocytosis of their hormone granules. The mechanism of 
glucagon secretion remains to be determined but, if revealed, could have a significant 
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Glucagon is a hormone produced and secreted from pancreatic α-cells in response 
to hypoglycemia. Glucagon acts on the liver to stimulate glycogenolysis and 
gluconeogenesis. The regulation of glucagon secretion is very important in maintaining 
glucose homeostasis. Uncontrolled glucagon secretion can lead to hyperglycemia, a 
problem that would only amplify the hyperglycemic condition often associated with Type 
2 Diabetes Mellitus (Baron et al., 1987; Basu et al., 2004; Shah et al., 2000). There are 
many opposing views on what may be controlling glucagon secretion and what cellular 
components are involved, but despite the decades of research into the mechanism, the 
exact pathway remains elusive. For example, Gopel and colleagues recognize that L-type 
Ca2+ current is not sufficient to sustain electrical activity and secretion itself, so glucagon 
release requires large depolarizations achieved through voltage-gated Na+ channels 
(Gopel et al., 2000). They believe that this mechanism allows for KATP channels to serve 
the same function in α-cells that they do in β-cells while still having paradoxical 
responses to glucose metabolism. However, others disagree with this proposal based on 
studies with KATP channel knockout mice that suggest no role of KATP channels in 
glucagon secretion. Liu and colleagues found adrenaline to directly stimulate glucagon 
secretion bypassing KATP channels (Liu et al., 2004). There is little agreement in the 
literature as to what ion channels are present in α-cells. Even the glucose-sensing 
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capability of the α-cell is controversial (Gromada et al., 2007; Miki et al., 2001; Rorsman 
et al., 2008). There is, however, a general agreement that glucagon secretion results from 
an increase in the intracellular Ca2+ concentration ([Ca2+]i)  (Gromada et al., 2007). 
The Transient Receptor Potential (TRP) family of ion channels in mammals is 
comprised of 6 subfamilies: TRPV (vanilloid), TRPC (canonical), TRPM (melastatin), 
TRPP (polycystin), TRPA (ankyrin), and TRPML (mucolipin). The subfamilies vary in 
their permeability and activation. The melastatin subfamily has 8 members (TRPM1-8). 
TRPM4 is a 6-transmembrane protein with C- and N-terminals on the intracellular side 
and a single channel conductance of 25 pS (Launay et al., 2002). It is a Ca2+-activated 
non-selective (CAN) cation channel permeable to monovalent cations, namely Na+ and 
K+. Activation of TRPM4 allows Na+ to enter, leading to cell depolarization. In non-
excitable cells, TRPM4 inhibits Ca2+ entry through store-operated channels (Launay et 
al., 2004), a necessary step for cell migration, appropriate immune response, and many 
other physiological actions (Barbet et al., 2008). In excitable cells, for example pancreatic 
β-cells, TRPM4 promotes Ca2+ entry through voltage-dependent Ca2+ channels (VDCCs) 
(Marigo et al., 2009), which allows for processes such as hormone secretion (Cheng et 
al., 2007). In β-cells, oscillations in the membrane potential result in oscillations in Ca2+ 
signals because each depolarization opens L-type Ca2+ channels and Ca2+ influx occurs. 
As a result, insulin is secreted in a pulsatile fashion (Gilon et al., 2002). Recent studies 
found that TRPM4 impacts Ca2+ signals in pancreatic β-cells and subsequently insulin 
secretion (Marigo et al., 2009). Because both pancreatic α- and β-cells are excitable, their 
mechanism for secretion may be similar. It is known that Ca2+ entry through VDCCs and 
the resulting increase in intracellular Ca2+ concentration of the α-cell is imperative for 
glucagon secretion (Barg et al., 2000; Gromada et al., 1997).  In the present study, we 
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hypothesized that TRPM4 is important for glucagon secretion in α-cells by controlling 
intracellular Ca2+ signals. Therefore, we characterized TRPM4 in the alpha-cell line, 
αTC1-6, and examined its function in glucagon secretion.  
 
2.2 RESEARCH DESIGN AND METHODS 
Cell Culture: The mouse pancreatic α-cell line, αTC1-6, was maintained in RPMI 1640 
with 10% FBS and aerated with 5% CO2 and 95% air at 37°C. All experiments were 
performed with cells from passages 37-45.  
RT-PCR:  RNA was extracted from INS-1, MIN-6, INR1G9 and αTC1-6 cells using the 
RNAqueous-4PCR® kit according to manufacturer’s instructions (Ambion, Austin, TX, 
USA).  The RNA was purified with DNase 1 treatment. Reverse transcription was 
performed using MMLV-Reverse Transcriptase and Oligo(dT) primers. PCR was 
performed using Ambion’s RETROscript® kit and TRPM4 primers with the sequences 
listed (forward/reverse [5’ to 3’]): GACCTGCTTATTTGGGCTCTG / 
AGATGGGAGTTGTGCTGTCC mouse; CACCAGCCAGTTGGCATACT / 
CGTGAGCAAGATGATGAAGG hamster; TTGGCATACTGGGAGACGCA / 
GGCCCAAGATCGTCATCGT rat. Mouse GAPDH primers with sequence 
(forward/reverse [5’ to 3’]) TGCTGAGTATGTCGTGGAGTCTA / 
AGTGGGAGTTGCTGTTGAAGTCG was used as a positive control for PCR, and 
ultrapure water was used as a negative sample for RNA. 
Immunocytochemistry: αTC1-6 cell suspension was fixed in 4% paraformaldehyde for 
10 min at RT then seeded on to poly-D-lysine coated coverslips. Next, cells were 
permeabilized with 0.1% Triton X-100 for 2 min. Cells were then immunostained with a 
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primary-antibody cocktail [anti-TRPM4 rabbit polyclonal antibody (1:600) + anti-
glucagon mouse monoclonal antibody (1:1000) (Sigma-Aldrich, Saint Louis, MO, 
USA)]. After sufficient washing with PBS, binding was detected with a secondary-
antibody cocktail [anti-rabbit-FITC (1:400) (eBioscience, San Diego, CA, USA) + anti-
mouse-Rhodamine Red-X (1:400) (Jackson ImmunoResearch Laboratories, West Grove, 
PA, USA)]. Immunofluorescence images were obtained by confocal microscope with the 
focus plane cutting through the nucleus. Using the sequential acquisition technique, first 
the FITC chromophore was excited with a laser at 488 nm, and emission was collected at 
wavelengths from 500-530 nm.  Then, Rhodamine Red-X was excited with a laser at 543 
nm, and emission was collected at wavelengths from 570-650 nm. 
Electrophysiology: Cells were maintained in standard modified Ringer’s solution of the 
following composition (in mM): NaCl 140, KCl 2.8, CaCl2 1, MgCl2 2, glucose 4, 
HEPES-NaOH 10, pH 7.2 adjusted with NaOH. The standard internal solution contained 
(in mM): Cs-glutamate 120, NaCl 8, MgCl2 1, Cs-BAPTA 10, HEPES-CsOH 10, pH 7.2 
adjusted with CsOH. The internal solution’s buffered Ca2+ concentration was adjusted as 
necessary with CaCl2 (calculated with WebMaxC http://www.stanford.edu/~cpatton/ 
webmaxcS.htm). The Na+-free modified Ringer’s solution contained (in mM): N-methyl-
D-glucamine (NMDG) 140, KCl 2.8, CaCl2 1, MgCl2 2, glucose 4, HEPES-CsOH 10, pH 
7.2 adjusted with CsOH.  The osmolarity of the solutions were ~300 mOsm/L. TRPM4 
currents were recorded in the tight-seal whole-cell configuration mode at 21-25 °C. High-
resolution current recordings were acquired by a computer-based patch-clamp amplifier 
system (EPC-10, HEKA, Lambrecht, Germany). Patch pipettes had resistances between 
4-7 MΩ. Immediately following establishment of the whole-cell configuration, voltage 
ramps of 50 ms duration spanning the voltage range of −100 to +100 mV were delivered 
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from a holding potential of 0 mV at a rate of 0.5 Hz over a period of 300-600 s. All 
voltages were corrected for a liquid junction potential of 10 mV between external and 
internal solutions, calculated using Igor PPT Liquid Junction Potential software 
(Wavemetrics, Portland, OR, USA). The half-maximal excitatory concentration (EC50) 
and Hill coefficient were also calculated using the Igor software with the formula: f(x)= 
(Ymin + (Ymax – Ymin) * (1 / (1 + (Kd / x) ^ n))) where Kd=EC50 and n=Hill coefficient. 
Generation of TRPM4 knockdown population: Using calcium chloride (0.6M CaCl2), 
293T cells were transfected with 3 plasmids containing sequences coding for the 
lentiviral vector genome (pccL backbone), viral packaging proteins (pdelta8.2R), or viral 
VSVG (pVSVG) envelope from the vesicular stomatits virus. The VSVG pseudotype 
envelope enhances infectivity of lentiviruses produced towards human cells, although 
mouse and rat cells can similarly be infected by this modified envelope lentivirus. The 
transient transfection procedure for viral production is performed to maintain safe 
handling of the virus and avoid generation of self-replicating particles. Lentivirus 
plasmids were obtained from Sigma-Aldrich (Saint Louis, MO, USA) in a pLKO.1 
backbone and contained either nonspecific control (SHC002) or shRNA specific for 
mouse TRPM4 (SHDNA-NM_175130, TRCN0000068684) under the control of the U6 
promoter, plus the puromycin resistance gene. We reconstructed the lentiviral vector in a 
pCCL backbone plasmid in order to generate a bicistronic construct expressing both 
puromycin resistance gene and a green fluorescence protein (GFP) reporter separated by 
an internal ribosome entry sequence, CMV.Puro(r).IRES.GFP. Lastly, using BstBI 
restriction enzyme cloning, we ligated into the previous vector the PCR-amplified U6p-
shRNA constructs (shc002, or shRNA specific for mouse TRPM4). The lentiviral vector 
therefore contains two expression cassettes, one driven by U6p, and another driven by 
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CMVp. The first is under the control of the RNA polymerase III promoter, U6, and 
includes the shRNA specific for mouse TRPM4 or a nonspecific control. Following the 
shRNA gene is an RNA polymerase II promoter, CMV, which controls transcription of 
the subsequent puromycin resistance gene and the GFP gene. These 2 genes are separated 
by an internal ribosome entry sequence to increase ribosome binding so the GFP gene 
gets translated. The second cassette ends with a woodchuck hepatitis post-transcriptional 
regulatory element (WPRE), shown to stabilize the RNA and improve viral titers (Klein 
et al., 2006). The final lentiviral vector, thus, has the configuration: 5’ pCCL--- U6p-
shc002--- CMV-Puro(r).IRES.GFP--WPRE-3’. Lentiviruses are produced in 293T cells 
and released into the media supernatant, which was collected at 48, 72, and 96 hours 
post-transfection, filtered using a 0.22 µm membrane, and stored at –80°C in aliquots. 
For determining viral concentration (titer), 200µl of either pure supernatant (1x), or 
dilutions of 1:10 or 1:100 were used to infect 293T cells (5x104) seeded in 24-well plates. 
Infection was performed in the presence of the transduction-enhancing agent Polybrene at 
8µg/ml for cells assayed for percentage of cells expressing GFP by flow cytometry 48h 
after infection. For infecting experimental cells a multiplicity of infection (MOI) of 5 
lentiviruses was used to transduce αTC1-6 cells. Cells were selected in 1µg/mL 
puromycin for one week, and percent of puromycin-resistant cells expressing GFP was 
determined by flow cytometry using FACScan (BD Biosciences, Franklin Lakes, NJ, 
USA). Puromycin-selected transduced cells were used for electrophysiology, Ca2+-
imaging, and glucagon secretion experiments.  
Calcium Imaging: Control and TRPM4 shRNA αTC1-6 cells were loaded with 5µM 
Fura-2AM for 30 minutes at 37°C. A Ca2+-imaging buffer containing (in mM) NaCl 136, 
KCl 4.8, CaCl2 1.2, MgSO4 1.2, HEPES 10, glucose 4, and 0.1% BSA, pH 7.3 was used 
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for Fura-2AM loading and perfusion throughout imaging experiments. Calcium 
measurements were obtained using a dual excitation fluorometric imaging system  
(TILL-Photonics, Gräfelfingen, Germany) controlled by TILLvisION software.  Fura-
2AM loaded cells were excited by wavelengths of 340 nm and 380 nm. Fluorescence 
emissions were collected at a wavelength of 540 nm at a frequency of 1 Hz and computed 
into relative ratio units of the fluorescence intensity derived from the different excitation 
wavelengths (F340/F380). 
Measurement of Glucagon Secretion: Control and TRPM4 shRNA αTC1-6 cells were 
plated into 24-well plates at ~4 x 105 cells/well and grown for 2-3 days. Measurement of 
glucagon secretion was accomplished by replacing the culture medium with modified 
KRB containing (in mM) NaCl 136, KCl 4.8, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, 
NaHCO3 5, HEPES 10, glucose 1.67, and 0.1% BSA, pH 7.3. After a 15-min 
equilibration period at 37°C, the KRB was removed from the well and replaced with 
KRB containing either 1mM L-Arginine, 1µM AVP, 20mM KCl, or 1µM BayK 8644 
and allowed to incubate for 30 min. The KRB was then collected and stored at -80°C for 
glucagon radioimmunoassay. Experiments were performed in quadruplicates and 
repeated three times. Data was normalized by cell number per well. 
Data analysis: Patch-clamp recordings are shown as means + S.E.M., and were plotted 
using Igor Pro 5 software program (Wavemetrics, Portland, OR, USA). Peak Ca2+ data 
and glucagon secretion values were both analyzed using a two-tailed, unpaired Student’s 





We first examined if the TRPM4 gene was expressed in a mouse pancreatic α-cell 
line and whether the channel was functional. By RT-PCR, we detected TRPM4 
transcripts in the mouse alpha-cell line, αTC1-6 (Fig. 2.1A).  The pancreatic α-cell line, 
INR1G-9, and β-cell lines MIN-6 and INS-1 were used as positive controls (Marigo et 
al., 2009). Although TRPM4 is expressed in both the hamster and mouse alpha-cell lines, 
we selected the mouse cell line, αTC1-6, for our studies because of the availability of 
molecular tools for knockdown experiments. The expression of the TRPM4 protein in 
αTC1-6 cells was then confirmed by immunocytochemistry. Figure 2.1B shows TRPM4 
(left panel) co-localization with glucagon (center panel) in αTC1-6 cells. 
 Next, we investigated if TRPM4 was functional using the patch-clamp technique. 
Increases in [Ca2+]i is known to activate TRPM4, a CAN channel (Launay et al., 2002). 
Therefore, we performed patch-clamp recordings with increasing buffered [Ca2+]i to 
determine if currents with the characteristics of those previously reported (Launay et al., 
2002) for the channel could be detected.  An increase in [Ca2+]i resulted in a 
concentration-dependent activation of TRPM4-like currents with maximal current 
amplitude obtained with 3µM buffered Ca2+ (Fig. 2.2A). The current-voltage (I/V) 
relationship taken at 600s after establishment of whole-cell configuration resembles those 
of TRPM4 (Fig. 2.2B) (Launay et al., 2002). The EC50 was 0.62µM with a Hill 
coefficient of 2.72 (Fig. 2.2C). TRPM4 is also a voltage-dependent channel in which 
hyperpolarization decreases and depolarization increases its open probability (Launay et 
al., 2002). Hence, we examined, in the α-cell line, its voltage dependency. Patch-clamp 















+60 mV resulted in a voltage-dependent activation of TRPM4 currents with the smallest 
current amplitude recorded at -60mV and the greatest at +60mV (Figs. 2.3A and 2.3C). 
The I/V relationships taken at 300s into the experiments resembled that of TRPM4 (Fig. 
2.3B) (Launay et al., 2002). Since TRPM4 conducts Na+ into cells, we replaced NaCl in 
the extracellular buffer with NMDG and recorded currents under 1µM intracellular 
buffered Ca2+ and +60mV HP conditions. The absence of extracellular Na+ resulted in a 





























Figure 2.1: TRPM4 is expressed in mouse pancreatic α-cell line. (A) RNA was 
extracted from mouse αTC1-6 cells and transcribed into cDNA. RT-PCR was 
performed with specific primers for TRPM4. The β-cell lines rat INS-1 and mouse 
MIN-6, and the α-cell line hamster INR1G-9 were used as positive controls for 
TRPM4, and GAPDH was used as a positive control for the PCR. (B) Immunostaining 
of αTC1-6 cells for TRPM4 (green, left panel) and glucagon (red, center panel) with 




relationship showed a shift in the reversal potential to the left due to hyperpolarization 
caused by the absence of Na+ entry (Fig. 2.4B). Based on these observations, we 
concluded that the observed current is mediated by TPRM4 and from now on we will 
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Figure 2.2: Calcium activates TRPM4 in pancreatic α-cell line in a dose-
dependent manner. (A) Average inward and outward currents of TRPM4 after 
intracellular perfusion with increasing buffered Ca2+ concentrations. Traces represent 
the mean + S.E.M. (n=3-6 cells/concentration) extracted at a holding potential of 
+60mV. (B) Current-voltage relationship (I/V) under experimental conditions 
described in (A) taken from representative cells at the peak current amplitude at 600s 
for each Ca2+ concentration. (C) A dose-response analysis resulted in a half maximal 



































Having characterized TRPM4 in αTC1-6 cells, we examined its role in Ca2+ 
signaling and glucagon secretion using a stable TRPM4 knockdown population generated 
with a lentiviral vector carrying shRNA, GFP reporter, and puromycin-resistance genes. 
Fluorescent-activated cell sorting (FACS) analysis revealed >96.5% GFP expression in 
the control and TRPM4 knockdown population (Fig. 2.5A-C). Furthermore, we 
confirmed TRPM4 inhibition by patch-clamp under elevated buffered Ca2+ conditions. A 































Figure 2.3: Voltage-dependent activation of TRPM4 in pancreatic α-cell line. (A) 
Average inward and outward currents in αTC1-6 cells in response to 1uM Ca2+ at 
+60mV, 0mV, and -60mV holding potential. Traces are mean + S.E.M. (n=6-9 cells) 
(B) Current-voltage relationship (I/V) under experimental conditions described above 
obtained at 300s from representative cells at the peak amplitude. (C) Average peak 





















occurred in knockdown cells compared to control cells (Fig. 2.6A). These experiments 
showed that channel knockdown was successful. The I/V relationship of the control cells 
still resembled that of TRPM4 indicating that transduction with the viral vector did not 

















Glucagon secretion from pancreatic α-cells requires increases in [Ca2+]i (Gromada 
et al., 1997). Therefore, we determined the impact of TRPM4 knockdown on Ca2+ signals 
in response to different stimuli. Perfusion of control cells with 1µM arginine vasopressin 
(AVP), a Gq-protein coupled receptor agonist in α-cells (Yibchok-Anun et al., 2000) 























Figure 2.4: Replacement of NaCl by N-methyl-D-glucamine (NMDG) in the 
extracellular buffer solution inhibits TRPM4 currents. Whole cell recordings in 
pancreatic α-cells in response to 1µM Ca2+ at +60mV holding potential. (A) Average 
inward and outward currents of control cells in NaCl solution compared to cells kept 
in extracellular buffer with NMDG replacing NaCl. Traces are mean + S.E.M. (n=3-6 
cells). (B) Current-voltage relationship (I/V) taken at 400s from a representative cell. 
Inset shows the hyperpolarizing effect resulting from removal of Na+ from the 




































Figure 2.5: Transduction of αTC1-6 cells with shRNA specific for TRPM4 using 
lentiviral vector. Fluorescent activated cell sorting was used to measure the 
percentage of GFP-positive cells of (A) non-transduced αTC1-6 cells, (B) αTC1-6 




















 However, inhibition of TRPM4 by shRNA significantly decreased the responses to AVP 
(P<0.0001). The effect of direct cell depolarization on Ca2+ signals was examined by 
perfusing cells with 1mM L-arginine (L-Arg) or 20mM KCl. TRPM4 inhibition 
decreased Ca2+ entry in response to both L-Arg (P<0.0001, Fig. 2.7B) and KCl 
(P<0.0001, Fig. 2.8A). In another experiment, direct activation of L-type Ca2+ channels 
with 1µM BayK 8644 also elicited a significantly smaller response in TRPM4 
knockdown cells (P<0.0001, Fig. 2.8B). Histograms show a comparison between basal 
and peak Ca2+ increase within the same group (Figs. 2.7,2.8). To assess parasympathetic 
control of Ca2+ signals, we perfused cells with 100µM acetylcholine, but neither control 
nor the TRPM4 knockdown cells responded to treatment (data not shown). 
After confirming the reduced responses in Ca2+ signals with TRPM4 knockdown, 




































Figure 2.6: Inhibition of TRPM4 function with shRNA inhibits channel activity 
in pancreatic α-cell line. Patch-clamp recordings in the whole-cell configuration were 
collected at +60mV holding potential under 1µM buffered Ca2+ concentration. (A) 
Average inward and outward currents in non-specific shRNA controls and in shRNA 
TRPM4 knockdown cells. Traces represent mean + S.E.M. (n=6-8 cells/group) (B) 
Current-voltage relationship (I/V) obtained from representative cells at 300s. 
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(Fig. 2.9). TRPM4 knockdown cells secreted significantly less glucagon compared to 
control cells when stimulated with 1 µM AVP (P<0.0001), 20mM KCl (P<0.0001), 1mM 



































































Figure 2.7: Inhibition of TRPM4 decreases the magnitude of stimulus-induced 
Ca2+ signals in pancreatic α-cell line. Average increase in [Ca2+]i during stimulation 
with 1µM AVP (A) or 1mM L-Arg (B) in control and TRPM4 shRNA cells. Right 
panel: basal Ca2+ (filled bar) and peak Ca2+ increase (open bar) for control shRNA and 
TRPM4 shRNA cells of each treatment group. Values are mean + S.E.M.; n=69-95 
cells per treatment from 3 independent experiments; * P<0.05 compared to basal Ca2+; 






















We have investigated for the first time the role of TRPM4 in glucagon secretion 
from pancreatic α-cells. Using RT-PCR and immunocytochemistry, we demonstrated 
TRPM4 gene expression and protein in the mouse pancreatic α-cell line, αTC1-6. 
































Figure 2.8: TRPM4 inhibition decreases stimulus-induced Ca2+ signals. Average 
increase in [Ca2+]i during stimulation with 20mM KCl (A) or 1µM BayK 8644 (B) in 
control and TRPM4 shRNA cells. Right panel: basal Ca2+ (black bar) and peak Ca2+ 
increase (white bar) for control shRNA and TRPM4 shRNA cells of each treatment 
group. Values are mean + S.E.M.; n=69-95 cells per treatment from 3 independent 
experiments; * P<0.05 compared to basal Ca2+; # P<0.05 comparing peak of control 



























suggesting that the channel is functionally active in αTC1-6 cells. By inhibiting TRPM4, 
using lentiviral transduction of TRPM4-specific shRNA, we were able to investigate its 
role in glucagon secretion. We found that TRPM4 inhibition decreased the magnitude of 
intracellular Ca2+ signals and glucagon secretion in response to several stimuli compared 
to controls. Similarly, TRPM4 knockdown decreases the responses to stimulation during 
Ca2+ imaging and insulin secretion experiments from β-cells (Cheng et al., 2007; Marigo 
et al., 2009). Despite being different cell types, both utilize VDCCs as the main pathway 
for Ca2+ influx and hormone secretion. The fact that suppression of TRPM4 in α-cells 
Figure 2.9: TRPM4 knockdown inhibits glucagon secretion in response to 
stimulation. Static incubation of control shRNA and TRPM4 shRNA αTC1-6 cells. 
Treatment of TRPM4 shRNA cells with AVP, KCl, L-Arg, and BayK 8644 decreased 
glucagon secretion compared to controls. Actual values for control shRNA and 
TRPM4 shRNA cells at basal conditions are 10.5 and 17.6 pg/10,000 cells 
respectively. (Data expressed as a percentage of the basal mean + S.E.M.; n=12 wells; 
* P<0.05 compared to basal of the same group; # P<0.05 compared to control cells 
with the same treatment).  
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with shRNA and a dominant-negative construct in β-cells resulted in similar observations 
strongly suggests a role for the channel in Ca2+ signaling and hormone secretion from 
islet cells. In addition to TRPM4, studies with TRPM5 in knockout mice, a closely 
related channel with similar function have shown loss of high frequency Ca2+ oscillations 
from islets and hyperglycemia in response to glucose overload (Brixel et al., 2010; 
Colsoul et al., 2010). TRPM5 activation at least in β-cells has been linked to rapid 
changes in intracellular Ca2+ concentration (Prawitt et al., 2003). However, its role in α-
cells remains to be determined. It is tempting to speculate that both channels might be 
working in a coordinated fashion to control Ca2+ signals and hormone secretion in 
response to different agonists. Two other members of the TRP family of ion channels 
(TRPM2 and TRPM3) were reported to control insulin secretion from β-cells (Togashi et 
al., 2006; Wagner et al., 2008), but their function in α-cells is unknown. 
The biophysical characterization of TRPM4 in our study of αTC1-6 cells revealed 
Ca2+-activated currents that are voltage-dependent and promote Na+ influx. These 
properties are similar to those described in other cells types (Earley et al., 2004; Launay 
et al., 2004; Marigo et al., 2009; Nilius et al., 2003) and confirm the presence of TRPM4 
in αTC1-6 cells. The EC50 for Ca2+-induced TRPM4 activation in αTC1-6 was 0.62µM 
with a Hill coefficient of 2.72. This is in line with our previous finding in the β-cell lines 
HIT-T15, RINm5F, MIN-6 and β-TC3 (Marigo et al., 2009). In the same report, patch-
clamp recordings in a hamster α-cell line revealed transient currents characterized by 
brief activation followed by channel closure. Our findings in mouse αTC1-6 cells differ 
from this observation, but are in agreement with the biphasic current pattern reported in 
most cell types. The difference in TRPM4 activity suggests that in hamster it may be 
involved in the control of transient Ca2+ increases rather than continuous oscillations. 
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Inhibition of TRPM4 by shRNA reduced the magnitude of Ca2+ signals in 
response to all stimuli tested.  L-Arginine as well as KCl depolarizes cells directly to 
open VDCCs. It is reasonable to speculate that TRPM4 activation may occur during Ca2+ 
influx in addition to release from intracellular stores, which would further contribute to 
cell depolarization and the elevation in intracellular Ca2+ signals. Stimulation of αTC1-6 
cells with AVP, a Gq-protein coupled receptor agonist in α-cells resulted in decreased 
Ca2+ signals in TRPM4 knockdown cells. Binding of AVP to its receptor leads to Ca2+ 
release from the endoplasmic reticulum (ER) followed by a secondary phase due to Ca2+ 
influx from the extracellular space. In this scenario, TRPM4 activation during Ca2+ 
release from the ER would lead to depolarization and Ca2+ influx via VDCCs. A similar 
observation was made during TRPM4 inhibition in β-cells stimulated with AVP (Marigo 
et al., 2009). When we tested the effect of BayK 8644 on Ca2+ signals there was also a 
decrease in the magnitude after TRPM4 knockdown. BayK 8644 is known to directly 
activate L-type VDCCs, however, it can inhibit T-type VDCCs (Wu et al., 1992). 
Because Ca2+ signals were reduced in TRPM4 knockdown cells, we have to consider the 
possibility of TRPM4 regulation of other VDCC types in α-cells. In fact, Gromada and 
colleagues (Gromada et al., 1997) reported that N-type VDCCs are the most important 
for Ca2+ influx and glucagon secretion. The regulation of N-type VDCCs by TRPM4 
remains to be determined. Increases in the intracellular Ca2+ results in glucagon secretion 
and is an essential step in the pathway leading to exocytosis (Barg et al., 2000; Gromada 
et al., 1997). The amount of glucagon secreted from αTC1-6 cells was directly related to 
the magnitude of Ca2+ signals observed in both control and TRPM4 knockdown groups 
when stimulated with AVP, KCl and L-Arg. However, treatment with BayK 8644 
resulted in increased glucagon secretion above basal in both groups. Perhaps direct 
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opening of L-type VDCCs is sufficient to promote Ca2+ influx to stimulate secretion. 
Although TRPM4 knockdown resulted in less glucagon release than controls, it agrees 
with the magnitude of Ca2+ signals during BayK 8644 stimulation. We also investigated 
the responses to acetylcholine in Ca2+ signaling and glucagon secretion, which is a 
neurotransmitter used physiologically by the parasympathetic nervous system to elicit 
glucagon secretion (Verspohl et al., 1990). Yet, neither control nor TRPM4 knockdown 
cells responded to treatment. We can speculate that the murine α-cell line used in the 
study may not have the receptors for acetylcholine. 
Based on our findings, we propose a model of glucagon secretion in which 
depolarization by TRPM4 contributes to the secondary phase of Ca2+ influx through 
VDCCs (Fig. 2.10). Direct depolarization, as with L-Arg and KCl, opens VDCCs 
allowing Ca2+ influx and glucagon secretion, but it also activates TRPM4. Sodium influx 
through TRPM4 depolarizes the membrane, resulting in an increase in Ca2+ signals. 
These events potentiate glucagon secretion. For Gq-protein coupled receptor agonists 
(e.g. AVP), Ca2+ release from the ER caused by an increase in IP3 activates TRPM4 
leading to depolarization. The depolarization opens VDCCS allowing Ca2+ influx during 
the secondary phase and sustained glucagon secretion. The findings in our study provide 
the foundation for further research into the specific components of the glucagon secretion 
pathway. Clarifying this mechanism may allow for the control of hyperglucagonemia in 
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Figure 2.10. Role of TRPM4 in stimulus-induced glucagon secretion. Solid arrows 
indicate steps in direct depolarization pathway. Dashed arrows indicate steps in Gq-
protein coupled receptor pathway. See text for details. AVP, arginine vasopressin; 
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potassium ion; L-Arg, L-arginine; VDCC, voltage-dependent Ca2+ channel; TRPM4, 
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Prior to this study the presence and function of TRPM4 in pancreatic α-cells was 
unknown. After identifying TRPM4 and carefully assessing its function in these cells, we 
were able to establish a relation between the control of Ca2+ entry and the control of 
glucagon release. We have learned that TRPM4 does affect Ca2+ signaling in the α-cell, 
and in turn glucagon secretion. Inhibition of TRPM4 in mouse αTC1-6 cells decreased 
Ca2+ signals and glucagon secretion in response to the stimuli: L-arginine, KCl, arginine 
vasopressin, and BayK 8644. Each of these stimuli utilizes a pathway that results in an 
increased [Ca2+]i  that stimulates exocytosis of glucagon granules. Based on the data 
presented in this thesis, we reason that TRPM4 is controlling the [Ca2+]i allowing for 
regulation of the amount of glucagon release. Depolarization caused by Na+ entry 
through TRPM4 directly controls the Ca2+ entry through VDCCs; this indicates TRPM4 
as a key player in the glucagon secretion pathway. These findings bring the field one step 
closer to uncovering the exact mechanism of glucagon secretion. The elucidation of this 
pathway has the potential to provide many new targets for the treatment of 
hyperglucagonemia in diabetic patients. 
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